FDA Approves Pfizer’s Next-Generation Pneumococcal Vaccine In Children

Reuters (4/28, Roy) reported that the FDA has approved Pfizer’s “next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years.” Pfizer’s “vaccine, Prevnar 20, offers more protection against the disease versus the company’...